Concepedia

Grzegorz Godlewski

GG

Statistics

Publications

50

Citations

4.2K

H-Index

33

Active since

1993

Affiliations

National Institute on Alcohol Abuse and Alcoholism(Current)

National Institutes of Health

Medical University of Białystok

University of Bonn

National Institute of Diabetes and Digestive and Kidney Diseases

Grzegorz Godlewski is an author at National Institute on Alcohol Abuse and Alcoholism specializing in medicine, pharmacology, and physiology.

Top concepts

MedicinePharmacologyPhysiologyHealthNeuropharmacologyMetabolic SyndromeCannabinoid PharmacologyDiabetesNeuroscienceObesity

Publications per year

1993–2024

50

Publications

50

Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice

Douglas Osei‐Hyiaman, Jie Liu, Liang Zhou et al. · Journal of Clinical Investigation · 2008 · 451 citations · Full text

Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity

Joseph Tam, Kiran Vemuri, Jie Liu et al. · Journal of Clinical Investigation · 2010 · 446 citations · Full text

Peripheral Cb1r, Cardiometabolic Risk, Human Obesity +17

Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes

Tony Jourdan, Grzegorz Godlewski, Adeline Bertola et al. · Nature Medicine · 2013 · 403 citations · Full text

Inflammation, Anti-inflammatory, Autoimmune Disease +14

Peripheral Cannabinoid-1 Receptor Inverse Agonism Reduces Obesity by Reversing Leptin Resistance

Joseph Tam, Jie Liu, Grzegorz Godlewski et al. · Cell Metabolism · 2012 · 342 citations · Full text

Obesity, Metabolic Syndrome, Cannabis Use +11

Hepatic Cannabinoid Receptor-1 Mediates Diet-Induced Insulin Resistance via Inhibition of Insulin Signaling and Clearance in Mice

Jie Liu, Liang Zhou, Keming Xiong et al. · Gastroenterology · 2012 · 171 citations · Full text

Obesity, Metabolic Syndrome, Cannabis Use +9

1–5 of 50